|
|
Pharmacogenetic tests in cancer chemotherapy: what physicians should know for clinical application. The Journal of pathology. 2011. Lee Soo-Youn, et al. [Article:20818641@PubMed] |
|
|
BRCA1 185delAG mutant protein, BRAt, up-regulates maspin in ovarian epithelial cells. Gynecologic oncology. 2010. O'Donnell Joshua D, et al. [Article:19906413@PubMed] |
|
|
A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer. The pharmacogenomics journal. 2010. Ho-Pun-Cheung A, et al. [Article:20644561@PubMed] |
|
|
Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks. The pharmacogenomics journal. 2010. Roukos D H. [Article:20975737@PubMed] |
|
|
Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women. Journal of medical genetics. 2009. Chan K Y-K, et al. [Article:18782836@PubMed] |
|
|
Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. American journal of human genetics. 2008. Antoniou Antonis C, et al. [Article:18355772@PubMed] |
|
|
Identification of susceptibility genes for cancer in a genome-wide scan: results from the colon neoplasia sibling study. American journal of human genetics. 2008. Daley Denise, et al. [Article:18313025@PubMed] |
|
|
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. American journal of human genetics. 2007. Antoniou Antonis C, et al. [Article:17999359@PubMed] |
|
|
The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2007. Kotsopoulos Joanne, et al. [Article:17507615@PubMed] |
|
|
Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer. Human mutation. 2007. Ramus Susan J, et al. [Article:17688236@PubMed] |
|
|
Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer. Journal of medical genetics. 2007. Simard Jacques, et al. [Article:16905680@PubMed] |
|
|
Network modeling links breast cancer susceptibility and centrosome dysfunction. Nature genetics. 2007. Pujana Miguel Angel, et al. [Article:17922014@PubMed] |
|
|
Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations. The New England journal of medicine. 2007. Rennert Gad, et al. [Article:17625123@PubMed] |
|
|
Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation. American journal of human genetics. 2006. Weber Frank, et al. [Article:16685647@PubMed] |
|
|
BRCA1-associated complexes: new targets to overcome breast cancer radiation resistance. Expert review of anticancer therapy. 2006. Chen Xiaowei, et al. [Article:16445371@PubMed] |
|
|
Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers. International journal of cancer. Journal international du cancer. 2006. Nkondjock André, et al. [Article:16032702@PubMed] |
|
|
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. International journal of cancer. Journal international du cancer. 2006. Gronwald Jacek, et al. [Article:16331614@PubMed] |
|
|
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006. Pierce Lori J, et al. [Article:16636335@PubMed] |
|
|
Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist. Science (New York, N.Y.). 2006. Poole Aleksandra Jovanovic, et al. [Article:17138902@PubMed] |
|
|
The consensus coding sequences of human breast and colorectal cancers. Science (New York, N.Y.). 2006. Sjöblom Tobias, et al. [Article:16959974@PubMed] |
|
|
Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2005. Weitzel Jeffrey N, et al. [Article:16030099@PubMed] |
|
|
Single nucleotide polymorphisms in clinical genetic testing: the characterization of the clinical significance of genetic variants and their application in clinical research for BRCA1. Mutation research. 2005. Judkins Thaddeus, et al. [Article:15829246@PubMed] |
|
|
Genetic epidemiology of BRCA1. Cancer biology & therapy. 2004. Couch Fergus J. [Article:15254414@PubMed] |
|
|
Understanding germ-line mutations in BRCA1. Cancer biology & therapy. 2004. Szabo Csilla I, et al. [Article:15254424@PubMed] |
|
|
Hereditary breast cancer in Jews. Familial cancer. 2004. Rubinstein Wendy S. [Article:15516849@PubMed] |
|
|
Hereditary ovarian cancer in Ashkenazi Jews. Familial cancer. 2004. Robles-Díaz Luis, et al. [Article:15516850@PubMed] |
|
|
Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2004. Metcalfe Kelly, et al. [Article:15197194@PubMed] |
|
|
Haplotype and linkage disequilibrium architecture for human cancer-associated genes. Genome research. 2002. Bonnen Penelope E, et al. [Article:12466288@PubMed] |
|
|
Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002. Frank Thomas S, et al. [Article:11896095@PubMed] |
|
|
Cancer Incidence in BRCA1 mutation carriers. Journal of the National Cancer Institute. 2002. Thompson Deborah, et al. [Article:12237281@PubMed] |
|
|
Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. Journal of the National Cancer Institute. 2002. Brose Marcia S, et al. [Article:12237282@PubMed] |
|
|
The frequency of founder mutations in the BRCA1, BRCA2, and APC genes in Australian Ashkenazi Jews: implications for the generality of U.S. population data. Cancer. 2001. Bahar A Y, et al. [Article:11466700@PubMed] |
|
|
BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. Cancer research. 2000. Baldwin R L, et al. [Article:11034065@PubMed] |
|
|
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet. 2000. Narod S A, et al. [Article:11130383@PubMed] |
|
|
Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene. 1999. Catteau A, et al. [Article:10208417@PubMed] |
|
|
BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group. American journal of human genetics. 1997. Stoppa-Lyonnet D, et al. [Article:9150149@PubMed] |
|
|
Population genetics of BRCA1 and BRCA2. American journal of human genetics. 1997. Szabo C I, et al. [Article:9150148@PubMed] |
|
|
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. American journal of human genetics. 1997. Abeliovich D, et al. [Article:9042909@PubMed] |
|
|
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA : the journal of the American Medical Association. 1997. Shattuck-Eidens D, et al. [Article:9333265@PubMed] |
|
|
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. The New England journal of medicine. 1997. Struewing J P, et al. [Article:9145676@PubMed] |
|
|
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. American journal of human genetics. 1996. Neuhausen S L, et al. [Article:8571953@PubMed] |
|
|
Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. American journal of human genetics. 1996. Berman D B, et al. [Article:8651293@PubMed] |
|
|
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nature genetics. 1996. Roa B B, et al. [Article:8841191@PubMed] |
|
|
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nature medicine. 1996. Tonin P, et al. [Article:8898735@PubMed] |
|
|
BRCA1 mutations in Ashkenazi Jewish women. American journal of human genetics. 1995. Tonin P, et al. [Article:7611288@PubMed] |
|
|
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. American journal of human genetics. 1995. Easton D F, et al. [Article:7825587@PubMed] |
|
|
Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. American journal of human genetics. 1995. Struewing J P, et al. [Article:7611277@PubMed] |
|
|
Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. American journal of human genetics. 1995. Friedman L S, et al. [Article:8533757@PubMed] |
|
|
Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer research. 1995. Takahashi H, et al. [Article:7606717@PubMed] |
|
|
A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA : the journal of the American Medical Association. 1995. Shattuck-Eidens D, et al. [Article:7837387@PubMed] |
|
|
The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature genetics. 1995. Struewing J P, et al. [Article:7550349@PubMed] |
|
|
Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families. Nature genetics. 1994. Simard J, et al. [Article:7894492@PubMed] |
|
|
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (New York, N.Y.). 1994. Miki Y, et al. [Article:7545954@PubMed] |
|
|
Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. American journal of human genetics. 1993. Easton D F, et al. [Article:8460634@PubMed] |
|
|
http://www.ashg.org/genetics/ashg/ashgmenu.htm. [URL:http://www.ashg.org/genetics/ashg/ashgmenu.htm] |
